High dose rate brachytherapy for carcinoma of the cervix

Current evidence on the safety and efficacy of high dose rate brachytherapy for carcinoma of the cervix appears adequate to support the use of this procedure provided that the normal arrangements are in place for consent, audit and clinical governance.

Clinicians should ensure that patients have appropriate counselling and pain management. In addition, use of NICE's information for the public is recommended.